Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Boston Therapeutics, Inc. | exh32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Boston Therapeutics, Inc. | exh31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Boston Therapeutics, Inc. | exh31_1.htm |
| 10-Q - BOSTON THERAPEUTICS, INC. 10-Q - Boston Therapeutics, Inc. | boston10q.htm |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Boston Therapeutics, Inc. (the "Company") for the quarter ending March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Conroy Chi-Heng Cheng, Interim Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
|
(1)
|
The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
Dated: May 10, 2016
|
By:
|
/s/ Conroy Chi-Heng Cheng
|
|
|
|
Conroy Chi-Heng Cheng
|
||
|
|
Interim Chief Financial Officer
|
||